Literature DB >> 6608953

Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large.

P Sipponen, M Kekki, M Siurala.   

Abstract

Age-related trends of gastritis and intestinal metaplasia (IM) were studied in 476 endoscopically examined and bioptically proved cases of gastric carcinoma (GC), 263 of which were of intestinal (IGC) and 213 of diffuse (DGC) types. Endoscopic biopsy specimens from the area around the tumour were available in all cases, and from the antrum and/or body distant from the tumour area in 238 cases. A representative sample of an endoscopically and bioptically examined Finnish population consisting of 431 subjects was used as control material. In patients with IGC the prevalence of atrophic gastritis in the gastric area affected by the tumour was higher and that of superficial gastritis lower than expected, and the age-group scores of gastritis and IM were situated above the age-dependent line of gastritis scores of controls in all age groups studied. This was seen to indicate a more rapid progression of gastritis in IGC patients than in the population at large. In the opposite area of the stomach, i.e. in the tumour-free area, the progression of gastritis and IM was virtually similar to that in controls. No such differences were seen with regard to DGC. It is concluded that IGC is dynamically closely linked to gastritis and IM, while in DGC no such relationship is demonstrable.

Entities:  

Mesh:

Year:  1984        PMID: 6608953      PMCID: PMC1976768          DOI: 10.1038/bjc.1984.80

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  A theory to the stochastic dynamic model building for chronic progressive disease processes with an application to chronic gastritis.

Authors:  E Hovinen; M Kekki; S Kuikka
Journal:  J Theor Biol       Date:  1976-03       Impact factor: 2.691

3.  Fine structure of intestinal metaplasia and adenocarcinoma of the human stomach.

Authors:  H Goldman; S C Ming
Journal:  Lab Invest       Date:  1968-02       Impact factor: 5.662

4.  A clinical and statistical follow-up study of atrophic gastritis.

Authors:  R Cheli; L Santi; G Ciancamerla; G Canciani
Journal:  Am J Dig Dis       Date:  1973-12

5.  Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23--27 years' follow-up examinations.

Authors:  T Ihamäki; M Saukkonen; M Siurala
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

6.  Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample.

Authors:  T Ihamäki; K Varis; M Siurala
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

7.  The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma.

Authors:  J R Jass; M I Filipe
Journal:  Histochem J       Date:  1981-11

8.  Pernicious anaemia as a risk factor in gastric cancer.

Authors:  L Elsborg; J Mosbech
Journal:  Acta Med Scand       Date:  1979

9.  A histochemical study of human alimentary tract mucosubstances in health and disease. I. Normal and tumours.

Authors:  A Gad
Journal:  Br J Cancer       Date:  1969-03       Impact factor: 7.640

10.  Intestinal metaplasia of the gastric mucosa.

Authors:  B C MORSON
Journal:  Br J Cancer       Date:  1955-09       Impact factor: 7.640

View more
  14 in total

1.  Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection.

Authors:  S E Patchett; P H Katelaris; Z W Zhang; E M Alstead; P Domizio; M J Farthing
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

2.  Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.

Authors:  A L Blum; H Bethge; J C Bode; W Domschke; G Feurle; K Hackenberg; B Hammer; W Hüttemann; M Jung; G Kachel
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

Review 3.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

4.  Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa.

Authors:  G A Rothery; D W Day
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

5.  Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers.

Authors:  N Kim; S H Lim; K H Lee; S E Choi; H C Jung; I S Song; C Y Kim
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

6.  Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology.

Authors:  A Wee; J Y Kang; M Teh
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

7.  Increased risk of gastric cancer in males affects the intestinal type of cancer and is independent of age, location of the tumour and atrophic gastritis.

Authors:  P Sipponen; M Kekki; M Siurala
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

8.  Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis.

Authors:  K Kashiwagi; M Watanabe; T Ezaki; T Kanai; H Ishii; M Mukai; T Hibi
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 9.  Chronic gastritis.

Authors:  Pentti Sipponen; Heidi-Ingrid Maaroos
Journal:  Scand J Gastroenterol       Date:  2015-04-22       Impact factor: 2.423

10.  Immunoreactive inhibin-like material in serum and gastric juice of patients with benign and malignant diseases of the stomach.

Authors:  S A Shanbhag; A R Sheth; S A Nanivadekar; N A Sheth
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.